Nephrotic syndrome nursing: reference guide for students

LS
By Lindsay Smith, AGPCNP
Updated March 25, 2026

Nephrotic syndrome nursing: reference guide for students

Nephrotic syndrome is a clinical syndrome — not a single disease — caused by glomerular damage that makes the kidney’s filtration barrier abnormally permeable to protein. The result is massive urinary protein loss, low serum albumin, and generalized edema. For nursing students, nephrotic syndrome is a high-yield NCLEX topic because it tests your understanding of oncotic pressure, fluid shifts, and pharmacology all at once.

This reference covers the classic triad, pathophysiology, causes, clinical presentation, diagnostics, nursing interventions, and medications — plus a side-by-side comparison with nephritic syndrome, which students reliably confuse on exams.


Quick reference: the classic triad

These four findings define nephrotic syndrome. NCLEX will expect you to recognize them immediately.

FindingThresholdMechanism
Proteinuria>3.5 g/24 hoursGlomerular basement membrane (GBM) permeability — protein leaks into urine
HypoalbuminemiaSerum albumin <3.0 g/dLUrinary loss outpaces hepatic synthesis
Edema (generalized)Periorbital, dependent, ascitesReduced oncotic pressure → fluid shifts from vascular to interstitial space
Hyperlipidemia / lipiduriaLDL and triglycerides elevated; oval fat bodies in urineHepatic overproduction of lipoproteins; lipoprotein loss impaired

Frothy or foamy urine is a classic symptom patients describe — it reflects high urinary protein concentration.


Pathophysiology

Step 1: GBM disruption

The glomerular filtration barrier has three layers: the fenestrated endothelium, the glomerular basement membrane, and podocytes (the outer epithelial layer). In health, this barrier keeps large proteins — albumin, immunoglobulins, clotting factors — in the bloodstream.

In nephrotic syndrome, the podocytes are damaged or the GBM loses its charge selectivity. Albumin and other proteins pass freely into the filtrate and appear in the urine. This is proteinuria.

Step 2: Hypoalbuminemia

The liver can increase albumin synthesis, but it cannot keep pace with urinary losses when proteinuria exceeds 3.5 g/day. Serum albumin falls below 3.0 g/dL, sometimes dramatically lower in severe disease.

Step 3: Reduced oncotic pressure and edema

Albumin is the primary driver of plasma oncotic pressure — the force that keeps fluid inside capillaries. When albumin drops, oncotic pressure falls. Fluid shifts from the intravascular space into the interstitial and third spaces, producing:

  • Periorbital edema (often the first sign, especially in children — prominent on waking)
  • Dependent pitting edema in the lower extremities
  • Ascites (fluid in the peritoneal cavity)
  • Pleural effusion (fluid in the pleural space)
  • Scrotal or labial edema in severe cases

Step 4: Compensatory renin-angiotensin-aldosterone activation

Reduced intravascular volume triggers baroreceptors to activate the RAAS and ADH pathways. The kidneys retain sodium and water — which worsens the edema rather than correcting it, because the fundamental problem (low oncotic pressure) persists. This is why diuretics alone may be insufficient in severe cases.

Step 5: Lipid dysregulation

The liver upregulates lipoprotein synthesis (particularly VLDL and LDL) in response to low oncotic pressure — a compensatory attempt to restore protein concentration. Simultaneously, the enzyme lipoprotein lipase, which normally breaks down circulating lipids, is lost in the urine. The result is hyperlipidemia. Lipoproteins also spill into the urine (lipiduria), where they appear as oval fat bodies and Maltese crosses under polarized light microscopy.


Causes and classification

Nephrotic syndrome is classified as primary (intrinsic glomerular disease) or secondary (caused by a systemic condition).

TypeCauseKey points
Primary — Minimal change disease (MCD)Idiopathic podocyte injuryMost common cause in children; associated with Hodgkin lymphoma in adults; responds well to corticosteroids
Primary — Focal segmental glomerulosclerosis (FSGS)Podocyte injury, scarring of some glomeruliMost common primary cause in adults; high recurrence after transplant; steroid-resistant forms exist
Primary — Membranous nephropathySubepithelial immune deposits; PLA2R antibody in most idiopathic casesMost common primary cause in middle-aged adults; associated with solid tumors, hepatitis B, lupus
Primary — Membranoproliferative GN (MPGN)Complement-mediated GBM thickening and mesangial expansionLess common; associated with infections, autoimmune disease, complement dysregulation
Secondary — Diabetic nephropathyChronic hyperglycemia → glomerulosclerosisMost common cause of nephrotic syndrome overall in adults; proteinuria may precede GFR decline
Secondary — Lupus nephritisImmune complex deposition; classified ISN/RPS Class I–VIClasses III, IV, V can present with nephrotic-range proteinuria
Secondary — AmyloidosisAL or AA amyloid deposits in glomeruliAL (plasma cell dyscrasia); AA (chronic inflammatory disease)
Secondary — InfectionsHepatitis B, hepatitis C, HIVHIV-associated nephropathy (HIVAN) most commonly causes collapsing FSGS

Clinical pearl for NCLEX: Minimal change disease in a child who responds to steroids = think MCD first. Nephrotic syndrome in a middle-aged adult with no obvious cause = think membranous nephropathy. Nephrotic syndrome in a diabetic patient with long-standing poorly controlled diabetes = think diabetic nephropathy.


Clinical presentation

Primary symptoms

  • Frothy/foamy urine — often the patient’s first complaint; protein creates surface foam
  • Periorbital edema — puffy eyelids, especially on waking; hallmark of nephrotic syndrome in children
  • Dependent edema — pitting edema in ankles and feet; progresses to legs and sacrum with worsening disease
  • Weight gain — rapid fluid accumulation; 1 kg ≈ 1 liter of retained fluid
  • Ascites — abdominal distension; shifting dullness on percussion
  • Pleural effusion — dullness to percussion at lung bases; decreased breath sounds
  • Fatigue — related to hypoalbuminemia, anemia, and systemic fluid shifts
  • Anorexia, nausea — common in moderate-to-severe disease

Complications

Hypercoagulability is among the most dangerous complications. Antithrombin III, protein C, and protein S are all lost in the urine. The net effect is a procoagulant state with significant risk of deep vein thrombosis (DVT), pulmonary embolism (PE), and renal vein thrombosis. Renal vein thrombosis classically presents with sudden flank pain and worsening proteinuria — it is most strongly associated with membranous nephropathy.

Infection risk increases because immunoglobulins (especially IgG) and complement factors are lost in the urine. Encapsulated organisms — particularly Streptococcus pneumoniae — pose the highest risk. Pneumococcal vaccine is recommended for patients with nephrotic syndrome.

AKI can occur concurrently with nephrotic syndrome due to reduced effective circulating volume, nephrotoxic medications, or underlying disease progression. See AKI nursing reference for staging and management.

Malnutrition develops over time from urinary protein losses, anorexia, and catabolism. Growth retardation can occur in children with prolonged nephrotic syndrome.

Hyperlipidemia complications — chronic hyperlipidemia accelerates atherosclerosis. Patients with long-standing nephrotic syndrome have elevated cardiovascular risk.


Diagnosis

Nephrotic syndrome is a clinical diagnosis based on the combination of findings. The workup proceeds in layers:

Confirming proteinuria:

  • 24-hour urine protein collection: >3.5 g in 24 hours is diagnostic. Instruct the patient to discard the first morning void, then collect all urine for 24 hours including the next morning’s first void.
  • Spot urine protein:creatinine (P:Cr) ratio: A ratio >3.5 mg/mg (or >3.5 g/g) correlates well with 24-hour protein excretion and is more convenient. Widely used in outpatient settings.
  • Urine dipstick: 3+ to 4+ protein suggests nephrotic-range proteinuria but is not quantitative. Highly alkaline or dilute urine can give false results.

Confirming hypoalbuminemia and lipid abnormalities:

  • Serum albumin <3.0 g/dL
  • Lipid panel: elevated total cholesterol, LDL, triglycerides
  • Urine microscopy: oval fat bodies, free fat droplets, Maltese crosses (with polarized light)

Identifying the cause:

  • Serum glucose, HbA1c (diabetes)
  • ANA, anti-dsDNA, complement levels C3/C4 (lupus)
  • Hepatitis B surface antigen, hepatitis C antibody, HIV
  • Serum protein electrophoresis (SPEP) and urine protein electrophoresis (UPEP) for amyloidosis/myeloma
  • PLA2R antibody (membranous nephropathy)
  • Renal biopsy: required for definitive diagnosis in adults and in children who fail to respond to steroids. The biopsy identifies the histological pattern (minimal change, FSGS, membranous, MPGN) and guides treatment decisions.

Monitoring:

  • Serum creatinine and BUN — track for AKI or CKD progression
  • Coagulation studies if anticoagulation is considered
  • CBC — assess for anemia, infection

Nursing interventions

Assessment priorities

Daily weight is the most reliable indicator of fluid retention and response to treatment. Weigh the patient at the same time each day, in similar clothing, before meals. A gain of >1 kg/day suggests fluid accumulation.

Intake and output (I&O) — strict measurement every shift. Urine output monitoring detects oliguria, which may signal AKI or severe volume depletion from over-diuresis.

Edema assessment:

  • Grade pitting edema using the 1+ to 4+ scale (1+ = 2 mm pit that rebounds quickly; 4+ = >8 mm pit, rebounds slowly)
  • Document location, symmetry, and progression — sacral edema in a bed-bound patient
  • Assess for pleural effusion (decreased breath sounds, dullness on percussion) and ascites (shifting dullness, fluid wave)
  • Periorbital edema: document at each assessment — worse in the morning, may decrease with activity

Blood pressure — hypertension is more prominent in nephritic syndrome but can occur in nephrotic syndrome, especially secondary causes. Monitor each shift.

Respiratory status — pleural effusion can compromise gas exchange. Assess oxygen saturation, work of breathing, and lung sounds.

Skin integrity — edematous tissue is fragile and prone to breakdown. Reposition every 2 hours, use pressure-relieving surfaces, apply barrier cream, avoid tape on edematous skin.

Signs of thrombosis — assess for unilateral leg swelling, calf tenderness, or redness (DVT); sudden dyspnea, pleuritic chest pain (PE); flank pain with hematuria (renal vein thrombosis).

Signs of infection — monitor temperature, WBC, signs of pneumonia or cellulitis. Patients are immunocompromised from immunoglobulin loss.

Dietary modifications

Sodium restriction (2 g/day) is a cornerstone of edema management. Educate patients to avoid processed foods, canned soups, cured meats, and added salt. Sodium restriction reduces fluid retention and lowers blood pressure.

Protein intake — this is a frequently tested concept and a common misconception. Historically, high-protein diets were recommended to replace urinary losses. Current evidence does NOT support this approach. High dietary protein increases glomerular hyperfiltration and worsens proteinuria. Current guidelines recommend moderate protein intake at approximately 0.8–1 g/kg/day — consistent with general healthy adult recommendations. Exceptions may apply in children or patients with significant malnutrition.

Fluid restriction — may be necessary in severe edema or dilutional hyponatremia, but is not universally applied. Individualize based on serum sodium and degree of edema.

Low-fat diet — recommended to help manage hyperlipidemia and reduce cardiovascular risk.

Fluid management

Diuresis must be balanced against the risk of worsening intravascular volume depletion (patients have third-spacing, not total fluid excess). Signs of over-diuresis include dizziness, orthostatic hypotension, rising creatinine, and reduced urine output.

Albumin infusion followed by a loop diuretic (IV furosemide) is used in refractory edema when serum albumin is critically low — the albumin temporarily expands the intravascular compartment, and the diuretic acts while it is transiently present. This is not a long-term fix; albumin is rapidly lost in the urine.

Thrombus prevention

  • Compression stockings for ambulatory patients with lower extremity edema
  • Encourage mobility and ambulation when safe
  • Monitor for signs and symptoms of DVT/PE at every assessment
  • Anticoagulation (typically warfarin or LMWH) is initiated prophylactically when serum albumin drops below 2.0–2.5 g/dL or when thrombotic risk is deemed high — particularly in membranous nephropathy
  • If anticoagulation is prescribed, monitor INR (warfarin) or anti-Xa levels (LMWH)

Infection prevention

  • Pneumococcal vaccine (PCV15/PPSV23) and influenza vaccine as recommended
  • Hand hygiene education for patient and family
  • Avoid live vaccines in patients on immunosuppressive therapy
  • Monitor temperature and CBC; treat infections promptly — delay in treating sepsis in an immunocompromised patient is dangerous

Patient education

  • Daily weight log — when to call the provider (>2 lb gain in 24 hours, or >5 lb in a week)
  • Sodium restriction — label reading, food choices
  • Medication adherence — especially corticosteroids; never stop abruptly
  • Signs of complications to report: leg swelling, chest pain, shortness of breath (thrombosis); fever, chills (infection); decreased urine output (AKI)
  • Avoid nephrotoxic agents: NSAIDs, certain antibiotics (aminoglycosides), iodinated contrast without hydration

Medications

Drug / ClassIndicationNursing considerations
Prednisone (corticosteroid)First-line for minimal change disease; used in other primary causesGive with food to reduce GI upset. Monitor blood glucose (steroid-induced hyperglycemia), blood pressure, weight, mood. Never stop abruptly — taper required. Bone protection (calcium + vitamin D) for long-term use.
Cyclophosphamide (alkylating agent)Steroid-resistant or steroid-dependent nephrotic syndromeMonitor CBC — bone marrow suppression. Ensure adequate hydration to prevent hemorrhagic cystitis. Monitor for infection. Contraindicated in pregnancy.
Tacrolimus / Cyclosporine (calcineurin inhibitors)Steroid-resistant FSGS; membranous nephropathyNephrotoxic — monitor serum creatinine and trough levels. Drug interactions via CYP3A4 (avoid grapefruit). Monitor blood pressure and glucose.
Rituximab (anti-CD20 monoclonal antibody)Steroid-dependent MCD, membranous nephropathyMonitor for infusion reactions (premedicate with acetaminophen/diphenhydramine). Reactivation of hepatitis B — screen before initiating. PML risk with prolonged use.
Furosemide (loop diuretic)Edema managementMonitor electrolytes — hypokalemia, hyponatremia, hypomagnesemia. Monitor creatinine for over-diuresis. Assess for ototoxicity with high IV doses. Daily weights.
ACE inhibitors / ARBs (e.g., lisinopril, losartan)Reduce proteinuria; renoprotectiveMonitor potassium — hyperkalemia risk. Monitor creatinine (GFR-lowering effect acceptable up to 30% above baseline). Avoid in pregnancy. Do not use ACE inhibitor + ARB together (additive AKI/hyperkalemia risk).
Statins (e.g., atorvastatin)Hyperlipidemia management; cardiovascular risk reductionMonitor LFTs at baseline. Myopathy risk — report muscle pain. Drug interaction with cyclosporine (increases statin levels).
Warfarin / LMWH (anticoagulation)DVT/PE prophylaxis when albumin <2.0–2.5 g/dLWarfarin: monitor INR (therapeutic range 2–3). LMWH: monitor anti-Xa in renal impairment. Assess for bleeding. Warfarin dose may need adjustment as albumin levels change.

Nephrotic vs nephritic syndrome: comparison table

This is the most tested comparison in renal nursing. Both involve glomerular damage, but the type of damage and clinical presentation differ.

FeatureNephrotic syndromeNephritic syndrome
Primary defectPermeability to protein (podocyte/charge barrier)Inflammation → hematuria, GFR decline
ProteinuriaMassive (>3.5 g/24h)Mild to moderate (<3.5 g/24h)
HematuriaMinimal or absentPresent — often dysmorphic RBCs, RBC casts
Urine appearanceFrothy/foamyTea-colored, cola-colored (“gross hematuria”)
HypoalbuminemiaYes — significantMild or absent
EdemaGeneralized — periorbital, dependent, ascitesMild periorbital edema possible
HypertensionMild if presentProminent — fluid/sodium retention
OliguriaMildMore prominent — reduced GFR
LipidsHyperlipidemia, lipiduriaNormal or mildly elevated
Key lab findingOval fat bodies, fatty castsRBC casts (pathognomonic for glomerulonephritis)
CausesMCD, FSGS, membranous nephropathy, diabetic nephropathyPost-streptococcal GN, IgA nephropathy (Berger disease), lupus nephritis Class III/IV, anti-GBM disease (Goodpasture)
Complement levelsNormal (most primary causes)Low C3 (post-strep, MPGN, lupus) or normal (IgA, anti-GBM)

Mnemonic tip: Think of nephrOtic as “O for Overflow” — protein overflows into urine. Think of nephrItic as “I for Inflammation” — inflammatory destruction that bleeds.


NCLEX-style practice questions

Question 1

A nurse is caring for a 6-year-old admitted with periorbital edema and frothy urine. Urine protein:creatinine ratio is 4.2 mg/mg. Serum albumin is 1.8 g/dL. The physician prescribes prednisone. Which assessment finding is the nurse’s highest priority to monitor?

A) Blood glucose B) Urine specific gravity C) Daily weight and edema distribution D) Bowel sounds

Answer: C. Daily weight and edema assessment directly tracks the primary problem — fluid retention from hypoalbuminemia. Blood glucose monitoring (A) is important with corticosteroids but is not the highest priority in acute edema management. Urine specific gravity (B) and bowel sounds (D) are less directly relevant at this stage.


Question 2

A patient with nephrotic syndrome and serum albumin of 1.6 g/dL develops sudden-onset right flank pain and worsening proteinuria on repeat urine dipstick. The nurse should alert the provider immediately because these findings suggest:

A) Urinary tract infection B) Acute kidney injury from over-diuresis C) Renal vein thrombosis D) Pleural effusion

Answer: C. Flank pain plus worsening proteinuria in a patient with severe hypoalbuminemia (high thrombotic risk) is the classic presentation of renal vein thrombosis. This is a serious complication most associated with membranous nephropathy. UTI (A) causes dysuria and frequency. Over-diuresis (B) causes declining urine output and rising creatinine without flank pain. Pleural effusion (D) presents with dyspnea and decreased breath sounds, not flank pain.


Question 3

A nurse is teaching a patient with nephrotic syndrome about diet. Which statement by the patient indicates a need for further teaching?

A) “I should weigh myself every morning before breakfast.” B) “I should eat more protein to replace what I’m losing in my urine.” C) “I should limit sodium to 2 grams per day.” D) “I should avoid adding salt to my food and read food labels.”

Answer: B. High-protein intake does NOT replace urinary losses effectively and worsens glomerular hyperfiltration and proteinuria. Current evidence supports moderate protein intake (0.8–1 g/kg/day). All other statements are correct.


Question 4

A patient with nephrotic syndrome has a serum albumin of 1.4 g/dL. The nurse notes bilateral lower extremity edema graded 3+ and decreased breath sounds at the right lung base. The provider orders furosemide 80 mg IV followed by 25% albumin 25 g IV. In what order should these be administered?

A) Albumin first, then furosemide B) Furosemide first, then albumin C) Both simultaneously via separate IV lines D) Furosemide only — albumin is contraindicated in nephrotic syndrome

Answer: A. Albumin is given first to temporarily increase intravascular oncotic pressure, expanding the vascular compartment so that furosemide has fluid to act on. Giving furosemide first in a patient with severely low albumin risks further reducing an already depleted intravascular volume, causing hemodynamic instability.


Question 5

The nurse is reviewing labs for a patient with nephrotic syndrome who is on prednisone and furosemide. Which lab value requires immediate action?

A) Serum potassium 3.1 mEq/L B) Serum albumin 2.2 g/dL C) Total cholesterol 280 mg/dL D) 24-hour urine protein 4.1 g

Answer: A. Potassium of 3.1 mEq/L is hypokalemia requiring immediate action — both furosemide and the underlying disease state promote potassium loss. Hypokalemia risks dangerous cardiac dysrhythmias. Albumin of 2.2 g/dL (B) and proteinuria of 4.1 g (D) are abnormal but expected findings in active nephrotic syndrome. Elevated cholesterol (C) is common and managed with statins, but is not an acute emergency. See electrolyte imbalances nursing reference for hypokalemia management.


Question 6

A nursing student is presenting a case study on a patient with tea-colored urine, RBC casts, hypertension, and mild proteinuria (1.8 g/24h). A classmate states this is consistent with nephrotic syndrome because of the proteinuria. Which response from the nurse instructor is most accurate?

A) “You are correct — proteinuria confirms nephrotic syndrome.” B) “These findings are more consistent with nephritic syndrome — hematuria, RBC casts, and hypertension point to glomerular inflammation rather than protein leak.” C) “The tea-colored urine indicates a urinary tract infection, not a glomerular disorder.” D) “RBC casts are not clinically significant in this context.”

Answer: B. The classic nephritic triad is hematuria (often gross, tea-colored), hypertension, and oliguria — with RBC casts being pathognomonic for glomerulonephritis. Proteinuria in nephritic syndrome is typically below 3.5 g/24h. Nephrotic syndrome produces massive proteinuria (>3.5 g) with minimal hematuria. This distinction is essential for NCLEX.